InvestorsHub Logo
icon url

skitahoe

03/25/24 11:18 PM

#455008 RE: crescentmotor #455005

Do you know if he's going after the UK as well. I believe both UK and EU's files are pretty similar, of course they were together until Brexit. NWBO is going after the UK as that's where their commercial manual manufacturing is and I really believe they need the approval of their EDEN unit to go much beyond the UK. I expect UK approval in the next two months so I see it as a big opportunity right now.

I have a feeling that Missling is like NWBO's CEO and able to keep it together on a shoestring until he gains an approval. Hopefully it will happen later this year, but if not, I suspect he'll find a way to do what's needed until he achieves that initial approval. IMGN operated much the same way, there was one period that they only had enough to pay people for two weeks.

The best such story was the CEO of FedEx not having enough to make payroll so he took what he had to Vegas and got lucky. It might be a very different world had he crapped out.

Gary
Bullish
Bullish
icon url

ignatiusrielly35

03/26/24 12:06 AM

#455013 RE: crescentmotor #455005

Wow, that is some serious hyperbole.
icon url

Steady_T

03/26/24 2:56 AM

#455015 RE: crescentmotor #455005

Your post assumes that the FDA won't approve an NDA for AD. Why is that?
icon url

BAR123

03/26/24 7:08 AM

#455019 RE: crescentmotor #455005

I think this is total BS. First off they are going forward with Rett syndrome and looking for approval based on the totality of the data. Just call and ask and they will tell you that. Secondly, A.D. results will come out via the peer review. We will at that point in time know how strong the data really is.from what I hear the results are still as we thought, coming out of phase 2, and that was very very good and better than any standard of care out there. So I’m not sure where you’re coming from to save the company is in Dire Straits as you portray.